Understanding Serum Inflammatory Markers in Pediatric Pneumonia

Overview

Journal World J Clin Pediatr

Publisher Baishideng Publishing Group

Date 2024 Dec 10

PMID 39654670

Authors

Basavraj S Nagoba

Shree V Dhotre

Ajay M Gavkare

Sachin S Mumbre

Pradnya S Dhotre

Affiliations

Soon will be listed here.

Abstract

This editorial reflects on the research, which investigates the potential of serum markers to predict the severity of infections. pneumonia (MPP) is a prevalent cause of respiratory infections in children, often leading to significant morbidity. Predicting the severity of MPP can significantly enhance patient management and outcomes. This editorial reviews the role of specific laboratory markers: (1) Lactate dehydrogenase; (2) Interleukin (IL)-6; (3) IL-10; (4) Tumor necrosis factor-α; and (5) D-dimer in predicting the severity of MPP in pediatric patients. Elevated levels of these markers are strongly associated with severe cases of MPP, providing clinicians with valuable tools for early diagnosis and targeted intervention.

References

Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y . Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021; 21(1):126. PMC: 7844890. DOI: 10.1186/s12879-021-05830-4. View

Morozumi M, Takahashi T, Ubukata K . Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010; 16(2):78-86. DOI: 10.1007/s10156-009-0021-4. View

Jain S, Williams D, Arnold S, Ampofo K, Bramley A, Reed C . Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015; 372(9):835-45. PMC: 4697461. DOI: 10.1056/NEJMoa1405870. View

Wang L, Hu Z, Jiang J, Jin J . Serum inflammatory markers in children with pneumonia and their predictive value for mycoplasma severity. World J Clin Cases. 2024; 12(22):4940-4946. PMC: 11238786. DOI: 10.12998/wjcc.v12.i22.4940. View

Liu B, Chang X, Yan N . Clinical analysis of the epidemiology and changes in inflammatory indexes of in acute and recovery stage pediatric patients. Transl Pediatr. 2022; 11(10):1645-1655. PMC: 9636459. DOI: 10.21037/tp-22-416. View

Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z . The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. PLoS One. 2016; 11(5):e0156465. PMC: 4882022. DOI: 10.1371/journal.pone.0156465. View

Tong L, Huang S, Zheng C, Zhang Y, Chen Z . Refractory Pneumonia in Children: Early Recognition and Management. J Clin Med. 2022; 11(10). PMC: 9144103. DOI: 10.3390/jcm11102824. View

Kutty P, Jain S, Taylor T, Bramley A, Diaz M, Ampofo K . Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis. 2018; 68(1):5-12. PMC: 6552676. DOI: 10.1093/cid/ciy419. View

Bradley J, Byington C, Shah S, Alverson B, Carter E, Harrison C . The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011; 53(7):e25-76. PMC: 7107838. DOI: 10.1093/cid/cir531. View

10.

Jain S, Finelli L . Community-acquired pneumonia among U.S. children. N Engl J Med. 2015; 372(22):2167-8. PMC: 9338769. DOI: 10.1056/NEJMc1504028. View

11.

Yang E, Kang H, Rhim J, Kang J, Lee K . Early Corticosteroid Therapy for Pneumonia Irrespective of Used Antibiotics in Children. J Clin Med. 2019; 8(5). PMC: 6572103. DOI: 10.3390/jcm8050726. View

12.

Principi N, Esposito S . Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 2010; 66(9):815-22. DOI: 10.1136/thx.2010.142604. View

13.

Atkinson T, Balish M, Waites K . Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008; 32(6):956-73. DOI: 10.1111/j.1574-6976.2008.00129.x. View

14.

Waites K, Talkington D . Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17(4):697-728, table of contents. PMC: 523564. DOI: 10.1128/CMR.17.4.697-728.2004. View

15.

Waites K, Xiao L, Liu Y, Balish M, Atkinson T . Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017; 30(3):747-809. PMC: 5475226. DOI: 10.1128/CMR.00114-16. View